Literature DB >> 8195605

A primate model for chancroid.

P A Totten1, W R Morton, G H Knitter, A M Clark, N B Kiviat, W E Stamm.   

Abstract

Adult pigtailed macaques (Macaca nemestrina) were evaluated for their usefulness as a primate model for chancroid. To initiate infection, 10(7)-10(8) cfu of Haemophilus ducreyi were inoculated into the foreskins of 5 adult males and into the vaginal labia of 4 adult females. Lesions developed in the male macaques that were similar in appearance, histopathologic changes, and progression to those of human disease, including the development of ulcers 6-12 days after infection. In addition, H. ducreyi could be recovered from the lesions up to 20 days after inoculation, humoral antibodies were induced beginning 1 week after inoculation, and inguinal lymphadenopathy was noted in 4 of the 5 males. None of the 4 female macaques inoculated with the same preparation of live H. ducreyi developed comparable lesions. Thus, experimental chancroid in adult male macaques closely resembles human disease and should be useful for future studies of the pathogenesis of chancroid.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195605     DOI: 10.1093/infdis/169.6.1284

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).

Authors:  Stanley M Spinola; Margaret E Bauer; Robert S Munson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Haemophilus ducreyi infection causes basal keratinocyte cytotoxicity and elicits a unique cytokine induction pattern in an In vitro human skin model.

Authors:  M M Hobbs; T R Paul; P B Wyrick; T H Kawula
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  A system for generalized mutagenesis of Haemophilus ducreyi.

Authors:  M K Stevens; L D Cope; J D Radolf; E J Hansen
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

4.  Use of tissue culture and animal models to identify virulence-associated traits of Haemophilus ducreyi.

Authors:  M J Alfa; M K Stevens; P DeGagne; J Klesney-Tait; J D Radolf; E J Hansen
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

5.  Characterization of a Haemophilus ducreyi mutant deficient in expression of cytolethal distending toxin.

Authors:  M K Stevens; J L Latimer; S R Lumbley; C K Ward; L D Cope; T Lagergard; E J Hansen
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

6.  Characterization of the hemolytic activity of Haemophilus ducreyi.

Authors:  P A Totten; D V Norn; W E Stamm
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 7.  Chancroid: clinical manifestations, diagnosis, and management.

Authors:  D A Lewis
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

Review 8.  Chancroid and Haemophilus ducreyi: an update.

Authors:  D L Trees; S A Morse
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

9.  Development of a rapid immunodiagnostic test for Haemophilus ducreyi.

Authors:  Kristine Patterson; Bonnie Olsen; Christopher Thomas; Dora Norn; Milton Tam; Christopher Elkins
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

10.  In vitro stimulation of peripheral blood mononuclear cells (PBMC) from HIV- and HIV+ chancroid patients by Haemophilus ducreyi antigens.

Authors:  L Van Laer; J Vingerhoets; G Vanham; L Kestens; J Bwayo; J Otido; P Piot; E Roggen
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.